$3.29
11.15% yesterday
Nasdaq, Jul 28, 10:00 pm CET
ISIN
US1511901050
Symbol
CELU

Celularity Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Celularity Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy
86%
Hold
14%

Celularity Inc - Ordinary Shares - Class A Price Target

Target Price $2.55
Price $3.29
Deviation
Number of Estimates 3
3 Analysts have issued a price target Celularity Inc - Ordinary Shares - Class A 2026 . The average Celularity Inc - Ordinary Shares - Class A target price is $2.55. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 7 analysts: 6 Analysts recommend Celularity Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Celularity Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of . Most analysts recommend the Celularity Inc - Ordinary Shares - Class A stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million $ 54.22 66.85
138.12% 23.29%
Net Margin -106.77% -14.45%
87.62% 86.47%

3 Analysts have issued a sales forecast Celularity Inc - Ordinary Shares - Class A 2025 . The average Celularity Inc - Ordinary Shares - Class A sales estimate is

$66.8m
Unlock
. This is
23.29% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$68.8m 26.92%
Unlock
, the lowest is
$64.2m 18.46%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $54.2m 138.12%
2025
$66.8m 23.29%
Unlock

3 Celularity Inc - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Celularity Inc - Ordinary Shares - Class A net profit estimate is

$-9.7m
Unlock
. This is
83.31% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-9.3m 83.97%
Unlock
, the lowest is
$-9.9m 82.83%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-57.9m 70.51%
2025
$-9.7m 83.31%
Unlock

Net Margin

2024 -106.77% 87.62%
2025
-14.45% 86.47%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -2.64 -0.43
76.04% 83.71%
P/E negative
EV/Sales 1.68

3 Analysts have issued a Celularity Inc - Ordinary Shares - Class A forecast for earnings per share. The average Celularity Inc - Ordinary Shares - Class A EPS is

$-0.43
Unlock
. This is
83.40% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.44 83.01%
Unlock
, the lowest is
$-0.41 84.17%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.64 76.04%
2025
$-0.43 83.71%
Unlock

P/E ratio

Current -1.14 95.27%
2025
-6.91 504.60%
Unlock

Based on analysts' sales estimates for 2025, the Celularity Inc - Ordinary Shares - Class A stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.07 16.87%
2025
1.68 18.74%
Unlock

P/S ratio

Current 1.31 15.16%
2025
1.06 18.89%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today